Literature DB >> 17569883

Thrombospondins, their polymorphisms, and cardiovascular disease.

Olga I Stenina1, Eric J Topol, Edward F Plow.   

Abstract

The thrombospondins are a 5-member gene family that mediate cell-cell and cell-matrix interactions. The thrombospondins are either trimers or pentamers, and their functions depend on their abilities to interact with numerous extracellular ligands and cell surface receptors through the multiple domains that compose each subunit. Recent genetic studies have indicated associations of particular single nucleotide polymorphisms in 3 of the 5 thrombospondins with cardiovascular disease. This observation has stimulated efforts to understand how the thrombospondins influence cardiovascular pathology, to dissect how the individual polymorphisms alter the structure and function of the parent thrombospondin molecules, and to replicate the genetic data in different patient populations. This review seeks to summarize current information that has emerged on each of these fronts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569883     DOI: 10.1161/ATVBAHA.107.141713

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  Emerging functions of matricellular proteins.

Authors:  David D Roberts
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

2.  Thrombospondin-1 Production Regulates the Inflammatory Cytokine Secretion in THP-1 Cells Through NF-κB Signaling Pathway.

Authors:  Tian Xing; Yao Wang; Wen-Jie Ding; Yuan-Ling Li; Xiao-Dong Hu; Cong Wang; Ao Ding; Ji-Long Shen
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 4.  Thrombospondin-4 in tissue remodeling.

Authors:  Olga Stenina-Adognravi; Edward F Plow
Journal:  Matrix Biol       Date:  2017-11-11       Impact factor: 11.583

5.  Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells.

Authors:  Nam-Gu Her; Santosh Kesari; Elmar Nurmemmedov
Journal:  Cell Cycle       Date:  2020-05-19       Impact factor: 4.534

6.  A thrombospondin-dependent pathway for a protective ER stress response.

Authors:  Jeffrey M Lynch; Marjorie Maillet; Davy Vanhoutte; Aryn Schloemer; Michelle A Sargent; N Scott Blair; Kaari A Lynch; Tetsuya Okada; Bruce J Aronow; Hanna Osinska; Ron Prywes; John N Lorenz; Kazutoshi Mori; Jack Lawler; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

7.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

8.  Mouse chromosome 17 candidate modifier genes for thrombosis.

Authors:  Qila Sa; Erika Hart; Joseph H Nadeau; Jane L Hoover-Plow
Journal:  Mamm Genome       Date:  2010-08-11       Impact factor: 2.957

9.  Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions.

Authors:  Y Li; H Choi; Z Zhou; L Nolasco; H J Pownall; J Voorberg; J L Moake; J-F Dong
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

Review 10.  Thrombospondins: old players, new games.

Authors:  Olga Stenina-Adognravi
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.